ES2061307T3 - Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas. - Google Patents
Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.Info
- Publication number
- ES2061307T3 ES2061307T3 ES92119073T ES92119073T ES2061307T3 ES 2061307 T3 ES2061307 T3 ES 2061307T3 ES 92119073 T ES92119073 T ES 92119073T ES 92119073 T ES92119073 T ES 92119073T ES 2061307 T3 ES2061307 T3 ES 2061307T3
- Authority
- ES
- Spain
- Prior art keywords
- psoriasic
- combat
- diseases
- active substance
- glycerol ethers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
- E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
- E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
- E02F3/92—Digging elements, e.g. suction heads
- E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel
Abstract
APLICACION DE AZELASTINA O SUS SALES UTILIZABLES TERAPEUTICAMENTE Y ETERES DE GLICERINA PARA LA PRODUCCION DE UN PREPARADO FARMACEUTICO PARA COMBATIR LAS ENFERMEDADES INFAMATORIAS Y LA PSORIASIS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3900607 | 1989-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061307T3 true ES2061307T3 (es) | 1994-12-01 |
Family
ID=6371863
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92119073T Expired - Lifetime ES2061307T3 (es) | 1989-01-11 | 1990-01-03 | Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas. |
ES90100071T Expired - Lifetime ES2063841T3 (es) | 1989-01-11 | 1990-01-03 | Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90100071T Expired - Lifetime ES2063841T3 (es) | 1989-01-11 | 1990-01-03 | Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5110814A (es) |
EP (2) | EP0533213B1 (es) |
JP (1) | JP2991733B2 (es) |
AT (2) | ATE113208T1 (es) |
AU (1) | AU618443B2 (es) |
CA (1) | CA2007480C (es) |
DE (3) | DE59007288D1 (es) |
DK (2) | DK0533213T3 (es) |
EG (1) | EG19912A (es) |
ES (2) | ES2061307T3 (es) |
HK (2) | HK50595A (es) |
IE (1) | IE65336B1 (es) |
MC (1) | MC2078A1 (es) |
PT (1) | PT92821B (es) |
SG (2) | SG30591G (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
NL9201438A (nl) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen. |
CZ199593A3 (en) * | 1992-10-02 | 1994-04-13 | Asta Medica Ag | Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr) |
US5569680A (en) * | 1995-02-13 | 1996-10-29 | Trustees Of The Univ. Of Penna | Method of treating inflammatory bowel disease with tributyrin |
JP4138910B2 (ja) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
US6984667B2 (en) * | 1998-04-08 | 2006-01-10 | Theta Biomedical Consulting And Development Co. | Synergistic proteoglycan compositions for inflammatory conditions |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
DE10028638A1 (de) | 2000-06-09 | 2001-12-20 | Schuelke & Mayr Gmbh | Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern |
EP1677766B1 (de) * | 2003-10-31 | 2012-03-14 | Hexal AG | Pharmazeutische wirkstoffhaltige formulierung mit überzug |
WO2005077963A1 (fr) * | 2004-01-16 | 2005-08-25 | Institut Superieur Agricole De Beauvais | DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes. |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
DK2522365T3 (en) | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
US8937178B2 (en) | 2013-03-13 | 2015-01-20 | Flatley Discovery Lab | Phthalazinone compounds and methods for the treatment of cystic fibrosis |
US10835584B2 (en) | 2016-06-17 | 2020-11-17 | Nuvothera, Inc. | Systems for treating dermal inflammatory conditions |
US11938139B2 (en) * | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840606A (en) * | 1969-12-05 | 1974-10-08 | Oreal | Process of producing mono and polyhydroxyl ethers |
CH572914A5 (es) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
DE3343530A1 (de) * | 1983-12-01 | 1985-06-13 | Max Planck Gesellschaft | Arzneimittel mit verbesserter penetration der gewebsmembran |
US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
-
1989
- 1989-12-28 US US07/458,350 patent/US5110814A/en not_active Expired - Lifetime
-
1990
- 1990-01-03 EP EP92119073A patent/EP0533213B1/de not_active Expired - Lifetime
- 1990-01-03 SG SG1995905105A patent/SG30591G/en unknown
- 1990-01-03 AT AT90100071T patent/ATE113208T1/de not_active IP Right Cessation
- 1990-01-03 DE DE59007288T patent/DE59007288D1/de not_active Expired - Lifetime
- 1990-01-03 AT AT92119073T patent/ATE111735T1/de not_active IP Right Cessation
- 1990-01-03 EP EP90100071A patent/EP0378086B1/de not_active Expired - Lifetime
- 1990-01-03 DK DK92119073.2T patent/DK0533213T3/da active
- 1990-01-03 SG SG1995905121A patent/SG30593G/en unknown
- 1990-01-03 ES ES92119073T patent/ES2061307T3/es not_active Expired - Lifetime
- 1990-01-03 DK DK90100071.1T patent/DK0378086T3/da active
- 1990-01-03 DE DE59007531T patent/DE59007531D1/de not_active Expired - Lifetime
- 1990-01-03 ES ES90100071T patent/ES2063841T3/es not_active Expired - Lifetime
- 1990-01-03 DE DE4000070A patent/DE4000070A1/de not_active Withdrawn
- 1990-01-04 MC MC902086A patent/MC2078A1/xx unknown
- 1990-01-08 EG EG1090A patent/EG19912A/xx active
- 1990-01-10 AU AU47862/90A patent/AU618443B2/en not_active Expired
- 1990-01-10 CA CA002007480A patent/CA2007480C/en not_active Expired - Lifetime
- 1990-01-10 IE IE9890A patent/IE65336B1/en not_active IP Right Cessation
- 1990-01-10 PT PT92821A patent/PT92821B/pt not_active IP Right Cessation
- 1990-01-11 JP JP2002630A patent/JP2991733B2/ja not_active Expired - Lifetime
-
1995
- 1995-04-06 HK HK50595A patent/HK50595A/xx not_active IP Right Cessation
- 1995-04-06 HK HK50495A patent/HK50495A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2007480A1 (en) | 1990-07-17 |
EP0533213B1 (de) | 1994-09-21 |
DE4000070A1 (de) | 1990-07-12 |
US5110814A (en) | 1992-05-05 |
IE900098L (en) | 1990-07-11 |
CA2007480C (en) | 1995-08-15 |
DK0533213T3 (da) | 1994-10-17 |
PT92821A (pt) | 1990-07-31 |
JPH02288827A (ja) | 1990-11-28 |
EP0378086A3 (de) | 1991-02-06 |
DE59007288D1 (de) | 1994-10-27 |
PT92821B (pt) | 1995-12-29 |
IE65336B1 (en) | 1995-10-18 |
EP0378086A2 (de) | 1990-07-18 |
EP0533213A1 (de) | 1993-03-24 |
AU618443B2 (en) | 1991-12-19 |
HK50595A (en) | 1995-04-13 |
ATE111735T1 (de) | 1994-10-15 |
AU4786290A (en) | 1990-07-19 |
HK50495A (en) | 1995-04-13 |
ES2063841T3 (es) | 1995-01-16 |
EG19912A (en) | 1996-05-31 |
DK0378086T3 (da) | 1994-12-12 |
ATE113208T1 (de) | 1994-11-15 |
SG30591G (en) | 1995-09-18 |
JP2991733B2 (ja) | 1999-12-20 |
SG30593G (en) | 1995-09-18 |
EP0378086B1 (de) | 1994-10-26 |
MC2078A1 (fr) | 1991-01-07 |
DE59007531D1 (de) | 1994-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061307T3 (es) | Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas. | |
DK0607128T3 (da) | Lægemiddel samt fremstilling deraf og anvendelse deraf ved bekæmpelsen af smerter og/eller betændelser hos dyr og mennesker | |
AR229581A1 (es) | Procedimiento para la elaboracion de derivados del alcohol 1-alpha-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico | |
ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
IT1148801B (it) | Derivati del nor-tropano, loro procedimento di preparazione e loro applicazione terapeutica | |
SE7905593L (sv) | Acylderivat av karnitin och forfarande for framstellning derav | |
ES2037808T3 (es) | Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus. | |
IT1151009B (it) | Derivati del 5h-furanone-2 e del 3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica | |
IT7821773A0 (it) | Endoscopio per l'esame di cavita'del corpo e per l'esecuzione di coagulazioni. | |
ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
IT7826263A0 (it) | Derivati del piranocromone e composizione terapeutica comprendente gli stessi, per il trattamento di malattie allergiche. | |
AR220548A1 (es) | Procedimiento para la preparacion de una heterovacuna para el tratamiento terapeutico del sindrome de trichomonas | |
SE7701441L (sv) | Nytt piperazinyluracilsalt | |
IT1159101B (it) | Procedimento per il trattamento del la colibacillosi neonatale e relativo composto farmaceutico | |
IT7868716A0 (it) | Derivati della benzammidina procedimento per la loro preparazione e loro impiego terapeutico | |
ES2054097T3 (es) | Agente para el tratamiento de enfermedades inflamatorias cronicas del intestino. | |
IT7823811A0 (it) | Composizione farmaceutica per il trattamento delle turbe del sonno. | |
IT1102304B (it) | Composizione farmaceutica per la cura della sordita' e del ronzio auricolare | |
IT7868550A0 (it) | Derivati del pacetamnidofenoloprocedimentp per la loro preparazione e loro impiego terapeutico | |
IT7921321A0 (it) | Derivati del paracetamolo ad azione terapeutica, procedimento per laloro preparazione e composizioni farmaceutiche relative. | |
IT7926323A0 (it) | Farmaco per la cura delle leucosi e di sindroni nevrotiche. | |
IT7822059A0 (it) | Derivati della alfa-feniletilammina ad azione terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT1166217B (it) | Composizione farmaceutica per la terapia delle sterilita' maschile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 533213 Country of ref document: ES |